National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease

Ann Intern Med. 2008 Jun 17;148(12):932-8. doi: 10.7326/0003-4819-148-12-200806170-00220. Epub 2008 May 5.
No abstract available

Publication types

  • Consensus Development Conference, NIH

MeSH terms

  • Adolescent
  • Adult
  • Anemia, Sickle Cell / drug therapy*
  • Antisickling Agents / adverse effects
  • Antisickling Agents / therapeutic use*
  • Biomedical Research
  • Child
  • Delivery of Health Care / standards
  • Health Services Accessibility
  • Humans
  • Hydroxyurea / adverse effects
  • Hydroxyurea / therapeutic use*
  • Infant
  • Pain / prevention & control
  • Patient Education as Topic / standards
  • Physician-Patient Relations

Substances

  • Antisickling Agents
  • Hydroxyurea